Glimstic MP2 Tablet is a bi-layered formulation designed to provide comprehensive glycemic control in patients with type 2 diabetes mellitus (T2DM). It combines three well-established antidiabetic agents: Glimepiride (2mg), Metformin Hydrochloride (500mg), and Pioglitazone (15mg), each playing a crucial role in lowering blood glucose levels and improving insulin sensitivity.
Managing diabetes requires a multi-targeted approach, and Glimstic MP2 effectively addresses insulin resistance, glucose production, and insulin secretion deficiencies, helping to prevent long-term complications associated with diabetes.
Mechanism of Action:
✔ Glimepiride (2mg): A sulfonylurea that enhances pancreatic beta-cell activity, leading to increased insulin secretion and effective blood glucose reduction.
✔ Metformin Hydrochloride (500mg): A biguanide that reduces hepatic glucose production, improves insulin sensitivity, and enhances glucose uptake by muscle cells.
✔ Pioglitazone (15mg): A thiazolidinedione that reduces insulin resistance, allowing the body to utilize insulin more efficiently and maintain balanced glucose levels.
